GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in dermatological products. Its stock price reflects the commercial success of its creams and gels, as well as its progress in developing new products.
Share prices of companies in the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing and commercializing treatments for skin conditions using its patented microencapsulation technology. We've classified it in the "Pharma Skin" segment. The graph below shows the overall dynamics of the dermatology pharmaceutical sector, where demand for effective and convenient products is high.
Broad Market Index - GURU.Markets
Sol-Gel Technologies is a dermatology company that uses its microencapsulation technology to create treatments for skin conditions. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Sol-Gel compares to it.
Change in the price of a company, segment, and market as a whole per day
SLGL - Daily change in the company's share price Sol Gel Technologies
For Sol-Gel Technologies, which operates in the dermatology sector, daily volatility reflects sensitivity to FDA approvals and the commercial success of its drugs. This metric is an important element in analyzing niche pharmaceutical companies.
Daily change in the price of a set of shares in a market segment - Pharma skin
Sol-Gel Technologies Ltd. is a pharmaceutical company. This chart highlights the sector's high volatility. Comparing it to SLGL, which focuses on dermatology, helps assess its risks compared to more diversified pharmaceutical companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Sol-Gel Technologies specializes in developing dermatological products. Using unique microencapsulation technology, the company addresses skin concerns. News of new creams and ointments being approved directly impacts its stock, and this "cosmetic" momentum, linked to health and beauty, is part of the overall market movement.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Sol Gel Technologies
Sol-Gel Technologies' year-over-year performance tells the story of its unique microencapsulation technology for dermatology. Its 12-month market cap growth reflects its success in securing approvals and commercializing its acne and rosacea treatments, as well as its partnerships with major pharmaceutical companies to develop new products.
Annual dynamics of market capitalization of the market segment - Pharma skin
Sol-Gel Technologies Ltd. is an Israeli dermatology company developing treatments for skin conditions using its unique microencapsulation technology. The chart below shows how the market views its innovative platform and clinical trial results compared to the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sol-Gel is a biopharmaceutical company whose stock performance is driven by the success of its drug sales and research progress. The company's business is not dependent on economic cycles. The chart reflects biotech events rather than macroeconomic data, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Sol Gel Technologies
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions. Its monthly performance reflects both the commercial success of its already approved products and news from its clinical programs. Quarterly sales reports are a key driver.
Monthly dynamics of market capitalization of the market segment - Pharma skin
Sol-Gel Technologies develops and commercializes dermatological drugs using its proprietary microencapsulation technology to enhance drug delivery. The company's success depends on the approval and sales of its products. A chart of the pharmaceutical sector will highlight general trends against which to evaluate the potential of Sol-Gel's niche technology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sol-Gel Technologies is a pharmaceutical company specializing in dermatological products. Demand for its products is relatively stable. The company's stock performance is less dependent on general economic trends and more determined by the successful commercialization of its creams and gels, as well as the results of new clinical trials.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Sol Gel Technologies
Sol-Gel Technologies, an Israeli dermatology company developing treatments for skin diseases, exhibits high volatility. Weekly stock performance depends on news about clinical trials and the commercial success of its products, reflecting the dynamics of the dermatology market.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Sol-Gel Technologies develops and commercializes drugs for the treatment of skin diseases using its unique microencapsulation technology. This chart compares its weekly performance with the pharmaceutical sector and helps understand how the market perceives its technological advantage in dermatology.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Sol-Gel Technologies is a pharmaceutical company. Its business depends on successful sales and patent protection. The chart will help you assess whether SLGL shares move with the market or are driven by unique factors.
Market capitalization of the company, segment and market as a whole
SLGL - Market capitalization of the company Sol Gel Technologies
Sol-Gel's chart is a financial map of innovation in dermatology. This Israeli company's market capitalization reflects its ability to create new treatments for acne and rosacea using its microencapsulation technology. Its dynamics are a barometer of its commercial success and progress in developing new skincare products.
SLGL - Share of the company's market capitalization Sol Gel Technologies within the market segment - Pharma skin
Sol-Gel's market share in the dermatology sector reflects its focus on developing skin medications based on its unique microencapsulation technology. Its market share is driven by the success of its acne and other skin condition treatments.
Market capitalization of the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing drugs to treat skin conditions. The chart below shows the overall market capitalization of the entire pharmaceutical industry. Its dynamics provide the backdrop against which Sol-Gel carves out its niche, offering new solutions for acne and rosacea.
Market capitalization of all companies included in a broad market index - GURU.Markets
Sol-Gel Technologies develops and commercializes dermatological drugs based on its unique microencapsulation technology. Its market capitalization reflects its niche expertise. The chart below shows the economic weight of companies with innovative drug delivery platforms.
Book value capitalization of the company, segment and market as a whole
SLGL - Book value capitalization of the company Sol Gel Technologies
Sol-Gel Technologies' book value is its capital and R&D equipment. The chart below shows the financial resources for the development and commercialization of its dermatological products. Its dynamics reflect research expenses and revenue from already approved products.
SLGL - Share of the company's book capitalization Sol Gel Technologies within the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing products using a unique microencapsulation technology. Production requires specialized facilities. The chart below shows how the company is building its physical infrastructure for the production of innovative products.
Market segment balance sheet capitalization - Pharma skin
Sol-Gel Technologies is a dermatology company. Its value lies in its unique microencapsulation technology. It's a "light" R&D model. The graph below illustrates how much the pharmaceutical industry relies on physical assets versus intellectual property.
Book value of all companies included in the broad market index - GURU.Markets
Sol-Gel Technologies' balance sheet is the intellectual property of a unique microencapsulation technology for creating dermatological medications. The company's assets represent capital invested in a platform that enables the creation of more effective and safe creams and gels for the treatment of skin conditions.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Sol Gel Technologies
Sol-Gel Technologies develops and commercializes drugs for the treatment of skin diseases. Its value lies in its patented microencapsulation technology. The chart shows how the market values its dermatological product portfolio and its ability to compete in this market.
Market to book capitalization ratio in a market segment - Pharma skin
Sol-Gel Technologies is a pharmaceutical company specializing in dermatological products. Its value lies in its patented microencapsulation technology. The chart shows how the market values this technology platform and its product portfolio.
Market to book capitalization ratio for the market as a whole
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. The chart shows how the market values this company, which boasts a unique drug delivery technology, valuing it at a premium to its assets reflects the potential of its platform for creating effective and easy-to-use treatments for skin conditions.
Debts of the company, segment and market as a whole
SLGL - Company debts Sol Gel Technologies
Sol-Gel Technologies develops and commercializes dermatological drugs. Debt can be used to finance clinical trials of new products and to build a commercial infrastructure to market approved drugs, as this chart illustrates.
Market segment debts - Pharma skin
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. The chart shows common financial indicators for the pharmaceutical sector, which can be used to assess how Sol-Gel funds clinical trials and the commercialization of its skincare products.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in dermatological products. Developing and launching even topical products requires clinical trials and costs. This chart shows how the company finances its operations. Debt levels are important for assessing its financial stability as it seeks to commercialize its products.
Market segment debt to market segment book capitalization - Pharma skin
Developing skin treatments like Sol-Gel's is a large but competitive market. This chart shows how the pharmaceutical sector as a whole funds its R&D. It allows us to appreciate how Sol-Gel Technologies' financial model, with its unique microencapsulation technology, differs from that of major dermatological manufacturers.
Debt to book value of all companies in the market
Sol-Gel Technologies develops and commercializes dermatological drugs using its proprietary microencapsulation technology. Pharmaceutical development requires significant capital. The chart helps assess how conservative their debt-based R&D funding strategy is.
P/E of the company, segment and market as a whole
P/E - Sol Gel Technologies
This chart for Sol-Gel Technologies, a dermatology company, shows its market valuation. The metric reflects how investors view its portfolio of skin treatments and its unique drug delivery technology, which encapsulates active ingredients.
P/E of the market segment - Pharma skin
This chart shows the average valuation for the specialty pharmaceutical sector, specifically dermatology, where Sol-Gel operates. This metric reflects how investors generally assess the prospects of companies developing skin treatments. It serves as a benchmark for evaluating Sol-Gel's technologies.
P/E of the market as a whole
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. This chart shows sentiment in the pharmaceutical sector. It helps understand whether the market sees a real advantage in Sol-Gel's technology for creating more effective and safe skin medications and how it assesses its commercial prospects.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs using its proprietary microencapsulation technology. The company's future depends on the success of its products. This chart shows how investors view its ability to bring new treatments for acne, rosacea, and other skin conditions to market.
%20P%2FE%20Sol%20Gel%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Sol-Gel-Technologies&v=1772560785102 "Chart of the company's future (projected) P/E Sol Gel Technologies")
Future (projected) P/E of the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions. The company's unique feature is its patented microencapsulation technology, which improves drug delivery. The chart reflects expectations for the biotech sector, helping to assess how the market views this technology platform.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772560785130 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. This chart of general expectations reflects investor sentiment toward the pharmaceutical industry. Market optimism facilitates raising capital for clinical trials and the launch of new, more effective skincare products.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772560785265 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. This chart shows the company's financial results as it launches its products. Profits are driven by sales of its creams and gels for the treatment of acne and other skin conditions.
Profit of companies in the market segment - Pharma skin
Vivakor, Inc. has developed a technology for cleaning up oil-contaminated soil and extracting hydrocarbons from it. Profitability depends on the commercialization of this environmental technology. This graph shows how solving environmental problems can become a business opportunity, but its profitability depends on the cost of the technology, regulations, and raw material prices.
Overall market profit
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of skin diseases. The company uses its patented microencapsulation technology to create new topical treatments. Its success depends on regulatory approval and demand for its products in dermatology.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. Its profit forecast depends on sales of approved products and the success of clinical trials. This chart shows analyst expectations for the market for drugs for the treatment of skin conditions such as acne and rosacea.
%20profit%20of%20the%20company%20Sol%20Gel%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Sol-Gel-Technologies&v=1772560785586 "Graph of future (projected) profit of the company Sol Gel Technologies")
Future (predicted) profit of companies in the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology for drug delivery. This chart shows profitability forecasts for the pharmaceutical sector. It highlights the potential of innovative delivery systems to improve the efficacy and safety of drugs in dermatology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772560785612 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Sol-Gel Technologies is a dermatology company developing medications for the treatment of skin diseases. Demand for its products is driven by medical needs. However, the overall economic outlook, reflected in this chart, impacts the solvency of patients and insurers, as well as the overall investment climate in the pharmaceutical industry.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772560785712 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Sol Gel Technologies
Sol-Gel Technologies is a dermatology company developing and commercializing treatments for skin conditions using its proprietary microencapsulation technology. The chart shows how investors view its product portfolio and technology, which improves drug delivery and tolerability for the skin.
P/S market segment - Pharma skin
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company developing and commercializing treatments for skin conditions using its proprietary microencapsulation technology. This chart shows the average valuation in the sector, allowing one to assess the market's perception of Sol-Gel's revenue potential.
P/S of the market as a whole
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. This chart, showing average valuations, helps understand the premium the market places on the revenue of this pharmaceutical company, which offers innovative solutions in the large dermatology sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. This chart shows how investors estimate future revenue from sales of its acne and rosacea treatment products. This estimate is based on demand forecasts and the company's ability to compete successfully in the dermatological market.
%20P%2FS%20Sol%20Gel%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Sol-Gel-Technologies&v=1772560785811 "The graph of the company's future (projected) P/S Sol Gel Technologies")
Future (projected) P/S of the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. This approach improves drug delivery and tolerability. The graph shows how the market estimates Sol-Gel's future sales, reflecting the potential of its innovative platform.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772560785841 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Market sentiment regarding future revenue depends on innovations in skin treatments. Sol-Gel Technologies develops dermatological drugs based on its unique microencapsulation technology. Their ability to improve existing medications, making them more effective and convenient, demonstrates how technology can create value even in mature markets.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772560785883 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in dermatology. The company's revenue is generated through sales of its approved acne and rosacea treatments, as well as royalties from partners. This chart shows how its unique skin drug delivery technology is translating into commercial success.
Sales of companies in the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company developing and commercializing skin treatments based on its proprietary microencapsulation technology. This chart shows total revenue in the dermatology pharmaceutical sector. It illustrates the demand for more effective and convenient treatments for acne, rosacea, and other skin conditions.
Overall market sales
Sol-Gel Technologies is a commercial-stage dermatology company developing and marketing medications for the treatment of skin conditions such as acne and rosacea. Its success depends on sales of existing products and the development of new ones. This global healthcare landscape impacts the demand for prescription dermatology medications and insurance coverage.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Sol Gel Technologies
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. Its future depends on the approval and commercialization of its products. The chart shows analyst revenue forecasts, reflecting their expectations for growth in the dermatology market.
%20sales%20of%20the%20company%20Sol%20Gel%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Sol-Gel-Technologies&v=1772560785940 "Schedule of future (projected) sales of the company Sol Gel Technologies")
Future (projected) sales of companies in the market segment - Pharma skin
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. The company uses its proprietary microencapsulation technology to improve drug delivery. This chart displays projected sales for the entire dermatological pharmaceutical segment, demonstrating overall growth expectations for this market.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772560785976 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Sol-Gel Technologies is a pharmaceutical company specializing in the development and commercialization of dermatological drugs. Its success depends on the approval and sales of its products. This general economic activity schedule influences the cosmetic and dermatological market, which is dependent on consumer spending and insurance coverage.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772560785999 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Sol Gel Technologies
Sol-Gel Technologies is a dermatology company developing drugs for the treatment of skin diseases. This metric reflects its transition from development to sales. It demonstrates how successfully the company converts revenue from its approved products into net profit while managing production and marketing costs.
Market segment marginality - Pharma skin
Sol-Gel Technologies is a dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. Profitability depends on the commercialization of its products, which reflects the operational efficiency of its business model compared to other dermatology pharmaceutical companies.
Market marginality as a whole
Sol-Gel Technologies is a commercial-stage dermatology company developing treatments for skin conditions using its proprietary microencapsulation technology. Their success depends on sales of their approved products and the results of new research. This overall profitability impacts them through consumer spending on medications.
Employees in the company, segment and market as a whole
Number of employees in the company Sol Gel Technologies
Sol-Gel Technologies is a pharmaceutical company specializing in dermatology, using its proprietary microencapsulation technology. This chart shows the size of its scientific and clinical teams. Growth here reflects progress in the development and commercialization of its drugs for the treatment of acne and other skin conditions.
Share of the company's employees Sol Gel Technologies within the market segment - Pharma skin
Sol-Gel Technologies develops and commercializes drugs for the treatment of dermatological diseases. This chart shows the percentage of chemists and dermatologists working on topical treatments the company attracts. Its team uses unique microencapsulation technology to improve drug delivery.
Number of employees in the market segment - Pharma skin
Sol-Gel Technologies is an Israeli pharmaceutical company specializing in the development and commercialization of dermatological drugs. This chart shows the overall employment in the skin pharmaceuticals sector. It illustrates how the company uses its patented microencapsulation technology to create more effective and safer drugs for the treatment of skin conditions.
Number of employees in the market as a whole
Sol-Gel Technologies is a dermatology company developing and commercializing treatments for skin conditions based on its proprietary microencapsulation technology. This graph illustrates the pharmaceutical labor market, where even niche players like Sol-Gel are making a difference by creating jobs for chemists, dermatologists, and sales professionals.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Sol Gel Technologies (SLGL)
Sol-Gel Technologies is a dermatology company developing drugs using its proprietary microencapsulation technology. This chart shows how the market values a company with a unique technological platform. The high market capitalization per employee suggests that investors see potential in the technology, not in the current activities of a small team.
%20of%20the%20company%20Sol%20Gel%20Technologies%20(SLGL)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Sol-Gel-Technologies-SLGL&v=1772560786201 "Chart of market capitalization per employee (in thousands of dollars) of the company Sol Gel Technologies (SLGL)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Sol-Gel Technologies is a dermatology company whose core value lies in its patented microencapsulation technology for drug delivery. This metric reflects the market's valuation of their intellectual property. Their high market capitalization per employee underscores that their value is generated by a small team of scientists, not mass production.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772560786220 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Sol-Gel Technologies is a pharmaceutical company specializing in skin treatments. It uses a unique microcapsule-based drug delivery technology. The employee's salary reflects the value of this technological platform and the portfolio of approved and future dermatological products.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772560786228 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Sol Gel Technologies (SLGL)
Sol-Gel Technologies (SLGL) is a pharmaceutical company specializing in dermatology. They have approved medications (creams). Their business is focused on R&D and commercialization. This chart shows the net financial result (profit or loss) from sales of their products per employee.
%20Chart%20Sol%20Gel%20Technologies%20(SLGL)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Sol-Gel-Technologies-SLGL&v=1772560786231 "Company Profit Per Employee (in thousands of dollars) Chart Sol Gel Technologies (SLGL)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Sol-Gel Technologies is a pharmaceutical company specializing in dermatological medications. They already have commercial products. This chart is a benchmark they strive to surpass. Their profitability per employee depends on how successfully their sales team can grow drug revenue to exceed R&D and marketing costs.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772560786235 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Sol-Gel (SLGL) is a pharmaceutical company specializing in dermatology. Their business is dual: they already sell approved skin treatments while simultaneously conducting R&D for new ones. This metric reflects their transition to the commercial stage, demonstrating how sales revenue generated by their team is beginning to cover the costs of their lab scientists.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772560786251 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Sol Gel Technologies (SLGL)
For Sol-Gel Technologies, a company developing skin treatments based on unique microencapsulation technology, this chart shows commercial progress. The increase in revenue per employee reflects successful sales of its dermatological creams and gels.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Sol-Gel-Technologies-SLGL&v=1772560786309 "Sales chart per company employee Sol Gel Technologies (SLGL)")
Sales per employee in the market segment - Pharma skin
Sol-Gel Technologies is a pharmaceutical company specializing in dermatology. They develop and commercialize drugs for the treatment of skin diseases. This metric reflects the average revenue per employee in the segment. It allows us to assess how productive Sol-Gel's team is in R&D and sales of its niche products compared to competitors.
Sales per employee for the market as a whole
Sol-Gel (SLGL) is a pharmaceutical company specializing in dermatology with approved drugs. This metric reflects their commercial success. The growth in revenue per employee demonstrates how effectively their relatively small team (including R&D and sales) is able to generate revenue from their proprietary creams and gels.
Short shares by company, segment and market as a whole
Shares shorted by company Sol Gel Technologies (SLGL)
Sol-Gel Technologies is an Israeli dermatology company that uses microencapsulation technology for drug delivery. It already has approved products. This chart reflects investor bets that its drugs will face stiff generic competition or that its commercial launch will be unsuccessful.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Sol-Gel-Technologies-SLGL&v=1772560786449 "Short Shares Chart for the Company Sol Gel Technologies (SLGL)")
Shares shorted by market segment - Pharma skin
Sol-Gel (SLGL) is a dermatology company developing topical treatments for skin conditions using a proprietary silica-based delivery system. This chart shows the overall short position in the pharmaceutical dermatology sector, reflecting market skepticism about their ability to compete in the crowded skincare market.
Shares shorted by the overall market
Sol-Gel Technologies specializes in dermatological drugs. Pharmaceuticals are often a defensive sector, but Sol-Gel is a growth company dependent on new product launches. This chart shows the overall pessimism. When investors are fearful, they may ignore R&D successes, preferring cash or dividend-paying giants.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Sol Gel Technologies (SLGL)
This chart reflects sentiment in the dermatology sector through Sol-Gel shares. The company develops medications (creams and gels) for the treatment of skin conditions. The market is eagerly awaiting FDA decisions. Approval of a new drug triggers euphoria and "overbought" sentiment (above 70). News of strong competition or a regulator's requirement for additional research quickly dampens investor enthusiasm (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Sol-Gel-Technologies-SLGL&v=1772560786498 "RSI 14 indicator chart for the company's stock Sol Gel Technologies (SLGL)")
RSI 14 Market Segment - Pharma skin
Sol-Gel (SLGL) is an Israeli biotech company that engineers skin. Their specialty is microencapsulation for improved delivery of acne and rosacea medications. The Pharma Skin (biotech) sector thrives on news. RSI_14_Seg shows the "temperature" of this entire segment. It helps us understand: is SLGL's growth driven by R&D, or is the entire biotech industry overheated?
RSI 14 for the overall market
Sol-Gel (SLGL) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SLGL (Sol Gel Technologies)
Sol-Gel is an Israeli pharmaceutical company specializing in dermatology. It uses its microencapsulation technology to create treatments for acne and rosacea. This chart shows the average analyst price target based on their sales growth forecasts for these approved medications.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SLGL-Sol-Gel-Technologies&v=1772560786551 "A chart showing analyst consensus forecasts for the expected stock price. SLGL (Sol Gel Technologies)")
The difference between the consensus estimate and the actual stock price SLGL (Sol Gel Technologies)
Sol-Gel (SLGL) is an Israeli dermatology company that uses its microcapsule technology to deliver medications for acne and psoriasis. This chart is a barometer of their R&D. It measures the gap between the price and the consensus target, reflecting the commercial potential analysts see for their skin treatments.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SLGL-Sol-Gel-Technologies&v=1772560786571 "A chart showing the difference between the consensus forecast and the actual stock price. SLGL (Sol Gel Technologies)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Sol-Gel Technologies is an Israeli dermatology company that uses microencapsulation technology to create improved creams (for acne and rosacea). This chart shows general expectations for the skin pharmaceutical sector. It reflects whether experts believe this drug delivery technology is competitive.
Analysts' consensus forecast for the overall market share price
Sol-Gel Technologies is an Israeli dermatology company developing products (creams and gels) for the treatment of acne and rosacea using its microencapsulation technology. This chart shows the overall market sentiment. For Sol-Gel, which operates in the healthcare sector, overall optimism is important, but their growth depends more on FDA approval and the successful commercialization of their niche products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Sol Gel Technologies
Sol-Gel is an Israeli dermatology company. Their signature technology is microencapsulation: they encapsulate well-known medications (for acne and rosacea) in microscopic capsules to make them more effective and less irritating. This graph is a summary of their R&D platform, reflecting their ability to commercialize their improved products.
AKIMA Market Segment Index - Pharma skin
Sol-Gel Technologies (SLNG) is a dermatology company developing and commercializing treatments for skin conditions (such as acne and rosacea) using its proprietary microencapsulation technology. The chart shows the average market share for the segment, helping investors assess how Sol-Gel competes in the dermatology market compared to the pharmaceutical industry average.
The AKIM Index for the overall market
Sol-Gel Technologies is a dermatology company developing topical products (creams) using silica encapsulation technology (for acne and rosacea). This chart, reflecting the market average, provides a macro backdrop. It helps assess how this Israeli company with commercial partnerships stacks up against overall economic trends.
